文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

塑料伤口保护器与手术纱布在开放胃肠手术中降低手术部位感染:一项随机临床试验

Plastic Wound Protector vs Surgical Gauze for Surgical Site Infection Reduction in Open GI Surgery: A Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2024-01-01

这项多中心、患者盲法、平行组随机临床试验于2017年8月至2022年10月在13家医院纳入458例开放腹部肠道手术患者,1:1随机使用双环塑料伤口保护器或传统手术纱布。意向性分析457例中,保护器组手术部位感染率为10.9%(25/229),纱布组为20.5%(47/229),相对危险度降低46.81%(95%CI 16.64%-66.06%)。

要点

  • 双环塑料伤口保护器组手术部位感染率为10.9%(25/229),手术纱布组为20.5%(47/229)。
  • 保护器显著降低手术部位感染风险,相对危险度降低46.81%(95%CI 16.64%-66.06%)。
  • 清洁-污染伤口亚组中保护器显著降低手术部位感染率(RRR 43.75%,95%CI 3.75%-67.13%)。

核心结论

  • 开放胃肠手术中使用塑料伤口保护器较手术纱布显著降低手术部位感染率,支持世界卫生组织关于腹部手术使用伤口保护器装置的推荐。

研究设计与样本

  • 多中心、患者盲法、平行组随机临床试验,2017年8月至2022年10月在13家学术机构医院开展。
  • 纳入接受开放腹部肠道手术(如肠穿孔)的患者,1:1随机分为双环塑料伤口保护器组(实验组)或传统手术纱布组(对照组)。
  • 共458例患者随机分组,对照组排除1例后,457例纳入意向性分析:保护器组229例,纱布组228例;平均(SD)年龄58.4(12.1)岁,男性256例(56.0%),清洁-污染伤口341例(74.6%)。

主要发现

  • 意向性分析总体手术部位感染率为15.7%(72/458)。
  • 保护器组手术部位感染率为10.9%(25/229),纱布组为20.5%(47/229),相对危险度降低46.81%(95%CI 16.64%-66.06%)。
  • 清洁-污染伤口中保护器显著降低手术部位感染率(RRR 43.75%,95%CI 3.75%-67.13%),尤其是表浅手术部位感染(RRR 42.50%,95%CI 7.16%-64.39%)。
  • 两组住院时间相似(均值[SD] 15.2[10.5]天 vs 15.3[10.2]天),总体术后并发症发生率相似(20.1% vs 18.8%)。

关键数值与推荐

  • 世界卫生组织推荐腹部手术中使用伤口保护器装置以降低手术部位感染风险。
  • 主要终点为开放胃肠手术后30天内手术部位感染率。

临床怎么用

  • 作者认为开放胃肠手术中使用塑料伤口保护器可显著降低手术部位感染率,支持世界卫生组织关于腹部手术使用伤口保护器装置的推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Surgical site infections (SSIs) are prevalent hospital-acquired infections with significant patient impacts and global health care burdens. The World Health Organization recommends using wound protector devices in abdominal surgery as a preventive measure to lower the risk of SSIs despite limited evidence. OBJECTIVE: To examine the efficacy of a dual-ring, plastic wound protector in lowering the SSI rate in open gastrointestinal (GI) surgery irrespective of intra-abdominal contamination levels. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, patient-blinded, parallel-arm randomized clinical trial was conducted from August 2017 to October 2022 at 13 hospitals in an academic setting. Patients undergoing open abdominal bowel surgery (eg, for bowel perforation) were eligible for inclusion. INTERVENTION: Patients were randomized 1:1 to a dual-ring, plastic wound protector to protect the incision site of the abdominal wall (experimental group) or a conventional surgical gauze (control group). MAIN OUTCOMES AND MEASURES: The primary end point was the rate of SSI within 30 days of open GI surgery. RESULTS: A total of 458 patients were randomized; after 1 was excluded from the control group, 457 were included in the intention-to-treat analysis (mean [SD] age, 58.4 [12.1] years; 256 [56.0%] male; 341 [74.6%] with a clean-contaminated wound): 229 in the wound protector group and 228 in the surgical gauze group. The overall SSI rate in the intention-to-treat analysis was 15.7% (72 of 458 patients). The SSI rate for the wound protector was 10.9% (25 of 229 patients) compared with 20.5% (47 of 229 patients) with surgical gauze. The wound protector significantly reduced the risk of SSI, with a relative risk reduction (RRR) of 46.81% (95% CI, 16.64%-66.06%). The wound protector significantly decreased the SSI rate for clean-contaminated wounds (RRR, 43.75%; 95% CI, 3.75%-67.13%), particularly for superficial SSIs (RRR, 42.50%; 95% CI, 7.16%-64.39%). Length of hospital stay was similar in both groups (mean [SD], 15.2 [10.5] vs 15.3 [10.2] days), as were the overall postoperative complication rates (20.1% vs 18.8%). CONCLUSIONS AND RELEVANCE: This randomized clinical trial found a significant reduction in SSI rates when a plastic wound protector was used during open GI surgery compared with surgical gaze, supporting the World Health Organization recommendation for use of wound protector devices in abdominal surgery. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03170843.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Yoo N, Mun JY, Kye BH, et al. Plastic Wound Protector vs Surgical Gauze for Surgical Site Infection Reduction in Open GI Surgery: A Randomized Clinical Trial. JAMA Surg. 2024. PMID: 38656413. doi:10.1001/jamasurg.2024.0765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。